Emmis Acquisition

EMISR · NASDAQ

$0.08+$0.00 (+0.00%)TodayMarket closed · Oct 23, 4:00 PM ET

Prev close $0.08

About EMISR

Emmis Acquisition Corp. operates as a blank check company. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2025-09-25. The firm is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm has not selected any business combination target, and it has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The company may pursue an initial business combination in any business or industry. The firm will not generate any operating revenue until after the completion of a business combination.

Employees: 0
Headquarters: FORT LAUDERDALE, Florida
Listed: Sep 25, 2025
Sector: N/A
Industry: N/A

EMISR key statistics

Market cap: 162.18M
Price-earnings ratio: 0.00
Dividend yield: —
Average volume: 5.89K
Volume: 1.97K
Open price: $0.08
High today: $0.08
Low today: $0.08
52 Week high: $0.185
52 Week low: $0.075

Emmis Acquisition (EMISR) at a glance

As of Oct 23, 2026, Emmis Acquisition (EMISR) shares are priced at $0.08, giving the company a market cap of 162.18M and a price-to-earnings ratio of 0.00.

Volume so far is 1.97K shares, below the average of 5.89K shares a day.

Over the past year Emmis Acquisition has ranged from $0.075 to $0.185, and now sits 5% of the way up that range.

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.